Detalhe da pesquisa
1.
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.
BMC Infect Dis;
13: 224, 2013 May 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23688546
2.
A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses.
Clin Ther;
32(13): 2186-97, 2010 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21316535